BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Palantir
PLTR
|
+$926M |
| 2 |
Sea Limited
SE
|
+$712M |
| 3 |
iShares Core MSCI Total International Stock ETF
IXUS
|
+$697M |
| 4 |
Wells Fargo
WFC
|
+$687M |
| 5 |
Blackstone
BX
|
+$652M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$16.4B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.4B |
| 3 |
Apple
AAPL
|
+$3.41B |
| 4 |
Microsoft
MSFT
|
+$3.3B |
| 5 |
Linde
LIN
|
+$2.07B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.52% |
| 2 | Healthcare | 13.51% |
| 3 | Financials | 13.07% |
| 4 | Consumer Discretionary | 11.27% |
| 5 | Communication Services | 8.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
KBAL
2626
DELISTED
Kimball International
KBAL
| $55.5M | ﹤0.01% |
4,219,988
-121,134
| -3% | -$1.65M |
|
2627
Sterling Infrastructure
STRL
$17B
| $55.5M | ﹤0.01% |
2,299,013
+7,001
| +0.3% | +$157K |
|
2628
Coca-Cola Femsa
KOF
$22.8B
| $55.4M | ﹤0.01% |
1,046,155
+152,392
| +17% | +$7.5M |
|
2629
Nurix Therapeutics
NRIX
$2.57B
| $55.4M | ﹤0.01% |
2,086,616
+269,927
| +15% | +$7.92M |
|
2630
State Street Energy Select Sector SPDR ETF
XLE
$37.8B
| $55.2M | ﹤0.01% |
2,050,380
-1,867,046
| -48% | -$48.6M |
|
2631
The RMR Group
RMR
$323M
| $55.1M | ﹤0.01% |
1,426,093
-4,626
| -0.3% | -$184K |
|
|
ALX
2632
Alexander's
ALX
$1.41B
| $55M | ﹤0.01% |
205,123
-396
| -0.2% | -$110K |
|
2633
Sumitomo Mitsui Financial
SMFG
$162B
| $54.8M | ﹤0.01% |
7,953,177
+12,844
| +0.2% | +$92.1K |
|
2634
Allegro MicroSystems
ALGM
$7.85B
| $54.8M | ﹤0.01% |
1,976,956
-616,866
| -24% | -$16.1M |
|
2635
IDEAYA Biosciences
IDYA
$3.49B
| $54.6M | ﹤0.01% |
2,602,423
+1,195,493
| +85% | +$24.6M |
|
2636
Lands' End
LE
$394M
| $54.6M | ﹤0.01% |
1,330,531
+88,400
| +7% | +$2.41M |
|
2637
YPF
YPF
$19.2B
| $54.5M | ﹤0.01% |
11,646,963
+486,903
| +4% | +$2.19M |
|
|
TRIL
2638
DELISTED
Trillium Therapeutics Inc.
TRIL
| $54.5M | ﹤0.01% |
+5,614,305
| New | +$52.8M |
|
2639
Mercer International
MERC
$44.9M
| $54.4M | ﹤0.01% |
4,268,924
-19,276
| -0.4% | -$286K |
|
2640
Johnson Outdoors
JOUT
$507M
| $54.4M | ﹤0.01% |
449,728
-24,858
| -5% | -$3.33M |
|
2641
CALL
iShares Russell 2000 ETF
IWM
$82.7B
| $54.3M | ﹤0.01% |
236,600
-2,208,600
| -90% | -$497M |
|
2642
ANI Pharmaceuticals
ANIP
$1.82B
| $54.2M | ﹤0.01% |
1,545,280
-106,005
| -6% | -$3.61M |
|
|
DFTX
2643
Definium Therapeutics
DFTX
$5.77B
| $54.1M | ﹤0.01% |
+1,045,634
| New | +$54.9M |
|
|
MRNS
2644
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $54.1M | ﹤0.01% |
3,015,028
+288,390
| +11% | +$4.64M |
|
|
FYBR
2645
DELISTED
Frontier Communications
FYBR
| $54.1M | ﹤0.01% |
+2,048,026
| New | +$51.6M |
|
|
DSPG
2646
DELISTED
DSP Group Inc
DSPG
| $54.1M | ﹤0.01% |
3,652,891
+11,320
| +0.3% | +$169K |
|
2647
Oportun Financial
OPRT
$281M
| $54M | ﹤0.01% |
2,693,541
+326,941
| +14% | +$6.7M |
|
2648
Accel Entertainment
ACEL
$1.02B
| $53.9M | ﹤0.01% |
4,544,023
+188,290
| +4% | +$2.34M |
|
|
DX
2649
Dynex Capital
DX
$3.17B
| $53.8M | ﹤0.01% |
2,884,495
+343,252
| +14% | +$6.73M |
|
2650
iShares MSCI France ETF
EWQ
$343M
| $53.6M | ﹤0.01% |
1,417,155
-374,346
| -21% | -$14.2M |
|
Similar funds
BlackRock's Q2 2021 Portfolio in Review
As of Q2 2021, BlackRock held 5,668 positions worth $3.59T, up 5.6% from $3.4T the previous quarter. Its ten largest holdings account for 18% of the portfolio.
BlackRock's Q2 2021 filing shows 333 new, 2,001 increased, 2,748 reduced and 150 closed positions. Its largest new stake was Organon & Co: 16,503,495 shares worth $499M. The largest sale was Alibaba, an estimated $16.4B.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.
- BlackRock's largest Q2 2021 buy was Organon & Co: 16,503,495 shares worth $499M.
- BlackRock added most to Palantir in Q2 2021, an estimated $926M increase.
- BlackRock's biggest Q2 2021 reduction was Alibaba, cutting an estimated $16.4B.
- BlackRock fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $1.35B.
- BlackRock's ten largest holdings make up 18% of its $3.59T portfolio in Q2 2021.
- BlackRock opened 333 new positions and closed 150 in Q2 2021.
- BlackRock's portfolio value rose 5.6% quarter-over-quarter to $3.59T.
Based on BlackRock's 13F filing for Q2 2021, filed 11 Aug 2021.